X

Health Care

Infographic: Key highlights from Merck’s (MRK) Q2 2023 earnings results

Merck (NYSE: MRK) reported second quarter 2023 earnings results today. Total worldwide sales were $15 billion, up 3% from the…

Ocean Biomedical shares details of its successful lung cancer program on World Lung Cancer Day

Biopharmaceutical company Ocean Biomedical, Inc. (NASDAQ: OCEA) provided details of its multi-pronged lung cancer program built on novel immunotherapy discoveries…

PFE Earnings: All you need to know about Pfizer’s Q2 2023 earnings results

Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today. Revenues decreased 54% year-over-year to $12.7 billion. Reported net…

Centene Corporation (CNC) Q2 2023 Earnings Summary

Centene Corporation (NYSE: CNC) reported second quarter 2023 earnings results today. Total revenues amounted to $37.6 billion compared to $35.9…

BSX Earnings: Highlights of Boston Scientific’s Q2 2023 results

Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the second quarter of 2023. The company also provided…

BMY Earnings: A snapshot of Bristol-Myers Squibb’s Q2 2023 results

Biotechnology company Bristol Myers Squibb (NYSE: BMY) on Thursday said its second-quarter adjusted earnings decreased year-over-year, hurt by a fall…

AbbVie (ABBV) Q2 2023 Earnings: Key financials and quarterly highlights

AbbVie (NYSE: ABBV) reported second quarter 2023 earnings results today. Worldwide net revenues were $13.8 billion, down 4.9% on a…

BIIB Earnings: A snapshot of Biogen’s Q2 2023 financial results

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the second quarter of…

Infographic: Thermo Fisher Scientific (TMO) Q2 2023 Earnings Results

Thermo Fisher Scientific Inc. (NYSE: TMO) reported second quarter 2023 earnings results today. Revenue declined 3% to $10.69 billion compared…

Intuitive Surgical (ISRG) reports higher Q2 revenues and earnings

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the second quarter of 2023, reporting higher revenues…

Key highlights from Abbott Laboratories (ABT) Q2 2023 earnings results

Abbott Laboratories (NYSE: ABT) reported second quarter 2023 earnings results today. Net sales decreased 11.4% year-over-year to $10 billion. Organic sales…

Johnson & Johnson (JNJ) Q2 2023 Earnings: Key financials and quarterly highlights

Johnson & Johnson (NYSE: JNJ) reported second quarter 2023 earnings results today. Reported sales increased 6.3% year-over-year to $25.5 billion.…

Novartis AG (NVS) Q2 2023 Earnings Call Transcript

Novartis AG (NYSE: NVS) Q2 2023 earnings call dated Jul. 18, 2023 Corporate Participants: Samir Shah -- Global Head, Investor Relations Vasant…

A look at the factors that influenced UnitedHealth’s Q2 earnings

Health insurance company UnitedHealth Group (NYSE: UNH) reported strong second-quarter results last week, triggering a stock rally. The company also…

UnitedHealth Group Incorporated (UNH) Q2 2023 Earnings Call Transcript

UnitedHealth Group Incorporated (NYSE: UNH) Q2 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk…

Organigram Holdings Inc (OGI) Q3 2023 Earnings Call Transcript

Organigram Holdings Inc (NASDAQ: OGI) Q3 2023 earnings call dated Jul. 14, 2023 Corporate Participants: Max Schwartz -- Director of Investor Relations…

Earnings Preview: Here’s what to expect from Johnson & Johnson’s Q2

Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) entered a new phase recently after spinning off its consumer business. The move…

Infographic: Highlights of UnitedHealth Group’s (UNH) Q2 2023 earnings

Diversified healthcare company UnitedHealth Group (NYSE: UNH) reported higher earnings and revenues for the second quarter of 2023. The company…

Theratechnologies Inc (THTX) Q2 2023 Earnings Call Transcript

Theratechnologies Inc (NASDAQ: THTX) Q2 2023 earnings call dated Jul. 12, 2023 Corporate Participants: John Mullaly -- Managing Director, LifeSci Advisors, LLC…

Angiodynamics Inc (ANGO) Q4 2023 Earnings Call Transcript

Angiodynamics Inc (NASDAQ: ANGO) Q4 2023 earnings call dated Jul. 12, 2023 Corporate Participants: Jim Clemmer -- Chief Executive Officer Steve Trowbridge -- Chief…

Earnings: AngioDynamics (ANGO) reports higher adj. profit for Q4; revenue up 5%

Medical device company AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported an increase in adjusted profit for the fourth quarter of…